Inventor · disambiguated record
David F. Mccomsey
Also filed as: MCCOMSEY DAVID · MCCOMSEY DAVID F · MCCOMSEY DAVID FRED
36 granted patents·3 pending applications·268 citations·filing 1976–2013
97Inventor score
Files withORTHO MCNEIL PHARM INC11JANSSEN PHARMACEUTICA NV10MCNEILAB INC5MCCOMSEY DAVID F3COSTANZO MICHAEL J1
Top patents by PatentIndex Score
39 records- 0193US6858577B1Indole peptidomimetics as thrombin receptor antagonistsORTHO MCNEIL PHARM INC·Filed 2000·Granted Feb 22, 2005·30 cites·10 claims
- 0291US7125878B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Oct 24, 2006·33 cites·26 claims
- 0390US4059583ASubstituted indolesMCNEILAB INC·Filed 1976·Granted Nov 22, 1977·23 cites·35 claims
- 0489US8084490B2Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disordersMCCOMSEY DAVID F·Filed 2005·Granted Dec 27, 2011·10 cites·20 claims
- 0589US6849643B2Indazolyl-substituted pyrroline compounds as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Feb 1, 2005·31 cites·20 claims
- 0687US6365617B1Indole and indazole urea-peptoids as thrombin receptor antagonistsORTHO MCNEIL PHARM INC·Filed 2000·Granted Apr 2, 2002·16 cites·19 claims
- 0786US7524858B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Apr 28, 2009·6 cites·30 claims
- 0886US5498629AAnticonvulsant pseudofructopyranose sulfamatesORTHO PHARMA CORP·Filed 1994·Granted Mar 12, 1996·40 cites·9 claims
- 0980US7232906B2Substituted pyrrolines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jun 19, 2007·11 cites·31 claims
- 1079US7781450B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Aug 24, 2010·2 cites·30 claims
- 1179US7705015B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Apr 27, 2010·2 cites·30 claims
- 1278US8008299B2Urotensin II receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Aug 30, 2011·3 cites·19 claims
- 1378US7786135B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 31, 2010·2 cites·7 claims
- 1478US4210590AReduction of indole compounds to indoline compoundsMCNEILAB INC·Filed 1978·Granted Jul 1, 1980·9 cites·12 claims
- 1577US6943149B2Benzimidazolone peptidomimetics as thrombin receptor antagonistsMILLENNIUM PHARM INC·Filed 2003·Granted Sep 13, 2005·5 cites·1 claims
- 1675US7183252B2Indole peptidomimetics as thrombin receptor antagonistsORTHO MCNEIL PHARM INC·Filed 2003·Granted Feb 27, 2007·2 cites·12 claims
- 1775US6740657B2Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonistsORTHO MCNEIL PHARM INC·Filed 2002·Granted May 25, 2004·8 cites·27 claims
- 1873US7759380B2Substituted pyrrolines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 20, 2010·1 cites·25 claims
- 1973US7608634B2Substituted pyrrolines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Oct 27, 2009·1 cites·10 claims
- 2069US6747127B1Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2000·Granted Jun 8, 2004·3 cites·9 claims
- 2167US7304060B2Indazolyl-substituted pyrroline compounds as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2004·Granted Dec 4, 2007·2 cites·17 claims
- 2260US7312306B2Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2003·Granted Dec 25, 2007·0 cites·16 claims
- 2358US8815939B2Substituted sulfamide derivativesMCCOMSEY DAVID F·Filed 2009·Granted Aug 26, 2014·0 cites·14 claims
- 2458US5521200A2-oxo-pyrrolo[1,2-A]benzimidazole-3-carboxyl derivatives useful in treating central nervous system disordersFiled 1994·Granted May 28, 1996·6 cites·17 claims
- 2557US7329657B2Indazolyl-substituted pyrroline compounds as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2004·Granted Feb 12, 2008·0 cites·16 claims
- 2656US6630451B1Benzimidazolone peptidometics as thrombin receptor antagonistORTHOMCNEIL PHARMACEUTICAL INC·Filed 2000·Granted Oct 7, 2003·7 cites·10 claims
- 2755US7855203B2Indazolyl-substituted pyrroline compounds as kinase inhibitorsORTHO MCNEIL JANSSEN PHARM·Filed 2007·Granted Dec 21, 2010·0 cites·13 claims
- 2851US5639760A3-oxo-pyrido(1,2-a)-benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)-benzimidazole-5-carboxyl derivatives useful in treating central system disordersFiled 1993·Granted Jun 17, 1997·7 cites·21 claims
- 2947US8853263B2Co-therapy for the treatment of epilepsy and related disordersSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Granted Oct 7, 2014·0 cites·17 claims
- 3047US5968946AHeterocyclic derivatives useful in treating central nervous system disordersORTHO MCNEIL PHARM INC·Filed 1998·Granted Oct 19, 1999·7 cites·15 claims
- 3145US8445514B2Urotensin II receptor antagonistsKINNEY WILLIAM A·Filed 2011·Granted May 21, 2013·0 cites·13 claims
- 3245US2008306044A1Spirobenzoazepanes as vasopressin antagonistsCOSTANZO MICHAEL J·Filed 2008·Application pending·0 cites
- 3345US2010240650A1Substituted pyrrolines as kinase inhibitorsZHANG HAN-CHENG·Filed 2010·Application pending·0 cites
- 3443US9024017B2Octahydro-cyclopentapyrrolyl antagonists of CCR2JANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 5, 2015·0 cites·13 claims
- 3543US4421917ADerivatives of 2-ureido-7-phenylhexahydrobenzo[a]quinolizinesMCNEILAB INC·Filed 1982·Granted Dec 20, 1983·1 cites·5 claims
- 3642US2005282887A1Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disordersMCCOMSEY DAVID F·Filed 2005·Application pending·0 cites
- 3733US4908450ACertain hexahydro-6-arylpyrrolo[2,1-A]isoquinolinesMCNEILAB INC·Filed 1989·Granted Mar 13, 1990·0 cites·2 claims
- 3832US4837328AStereoselective reaction for hexahydro-6-arylpyrrolo(2,1-A) isoquinolinesMCNEILAB INC·Filed 1988·Granted Jun 6, 1989·0 cites·16 claims
- 3931US6218384B13-Oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disordersORTHO MCNEIL PHARM INC·Filed 1997·Granted Apr 17, 2001·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →